Optimization of an Experimental Vaccine To Prevent Escherichia
Por um escritor misterioso
Descrição
Intranasal COVID-19 vaccines: From bench to bed - eBioMedicine
PDF) Optimization of an Experimental Vaccine To Prevent Escherichia coli Urinary Tract Infection
Development in the Concept of Bacterial Polysaccharide Repeating Unit-Based Antibacterial Conjugate Vaccines
Current status of experimental models for the study of malaria, Parasitology
Frontiers Challenges Associated With the Formation of Recombinant Protein Inclusion Bodies in Escherichia coli and Strategies to Address Them for Industrial Applications
Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera - eBioMedicine
Frontiers Optimization of SARS-CoV-2 Spike Protein Expression in the Silkworm and Induction of Efficient Protective Immunity by Inoculation With Alum Adjuvants
Accelerating model-informed decisions for COVID-19 vaccine candidates using a model-based meta-analysis approach - eBioMedicine
Experimental Vaccines Offer Long-term Protection Against Severe COVID, Newsroom
Vaccines Against Escherichia coli
Preventing the next pandemic - MIT Science Policy Review
Strategies for efficient production of recombinant proteins in Escherichia coli: alleviating the host burden and enhancing protein activity, Microbial Cell Factories
Prioritizing vaccination by age and social activity to advance societal health benefits in Norway: a modelling study - The Lancet Regional Health – Europe
de
por adulto (o preço varia de acordo com o tamanho do grupo)
